Best for Pregnancy
Best EPA for Pregnancy
Rankings coming soon · Reviewed May 2026 · 500–2000 mg clinical dose
Why EPA for Pregnancy
EPA plays a supporting role in pregnancy. EPA is the primary anti-inflammatory omega-3 fatty acid. EPA-dominant formulas (≥60% EPA) outperform DHA-dominant formulas for mood and depression in multiple meta-analyses.
What dose to look for
Clinical studies typically use 500–2000 mg of epa. 500mg minimum for general benefit; 1000-2000mg for mood/cardiovascular outcomes. Products below this range may not deliver meaningful results.
What the research says
EPA has strong clinical evidence for pregnancy benefits. REDUCE-IT (n=8,179) showed 25% CV event reduction with pure EPA. Meta-analyses of 26 RCTs confirm EPA-dominant formulas superior for depression. Learn more
Clinical research on Omega-3 Fatty Acids (DHA/EPA)
MODERATE — decent preterm-birth signal; cognition claims weaker and largely null in fish-replete mothers · ≥200 mg/day DHA in pregnancy and lactation (ACOG/AAP floor); prefer algal DHA over fish oil to avoid methylmercury. DHA is the pregnancy-relevant fraction; EPA contributes little here
- •DOMInO (largest prenatal DHA RCT): 800 mg/day DHA did not improve infant Bayley cognitive scores at 18 months — and stayed null at 4- and 7-year follow-up. A secondary signal of fewer very-low-birthweight births. PubMed
- •ORIP (largest single preterm-birth trial): 900 mg/day DHA-dominant n-3 did not reduce early preterm birth (<34 weeks) at the population level, with only a subgroup signal in women with low baseline n-3 status. PubMed
- •KUDOS: 600 mg/day algal DHA modestly increased gestational length (~2.9 days) and birth size; later cognitive endpoints were largely null. Birth-outcome effects were the cleanest signal. (Industry-funded.) PubMed
- •DHA is the pregnancy-relevant fraction — it accretes in fetal brain and retina, fastest in the third trimester. EPA is the cardiovascular/mood fraction with no distinct prenatal role, so pregnancy formulas should be DHA-led.
- •Honest read: the mechanism is solid but RCT effect sizes are small in fish-replete populations; the strongest case is mothers with very low fish intake. Marketing implying clear infant-IQ gains overstates what the controlled trials deliver.